urea has been researched along with Asthma in 46 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Asthma: A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL).
| Excerpt | Relevance | Reference |
|---|---|---|
| " We examined the effect of 1 week treatment with BAY 19-8004 (5 mg once daily), a novel orally administered PDE4 inhibitor, on trough FEV1 and markers of inflammation in induced sputum in patients with asthma or chronic obstructive pulmonary disease (COPD)." | 9.10 | Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). ( Benschop, N; Gauw, SA; Grootendorst, DC; Hiemstra, PS; Rabe, KF; Sterk, PJ, 2003) |
| " This study was done to determine the effects of exposure to urea-formaldehyde foam insulation (UFFI) off products on various hematologic and immunologic parameters in subjects with asthma: complete blood count and differential, erythrocyte sedimentation rate, lymphocyte subpopulations (E-rosetting, T3, T4, T8, B73." | 7.67 | Immunologic studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI) off products. ( Clark, RH; Day, JH; Lees, RE; Pross, HF, 1987) |
| "Two carpenters developed asthma and rhinitis related to occupational exposure to a cedar urea formaldehyde (CUF) particle board." | 7.66 | Occupational asthma caused by cedar urea formaldehyde particle board. ( Cockcroft, DW; Dolovich, J; Hoeppner, VH, 1982) |
| "A patient developed severe asthma following insulation of her house with urea-formaldehyde foam." | 7.66 | Asthma induced by dust from urea-formaldehyde foam insulating material. ( Filley, WV; Frigas, E; Reed, CE, 1981) |
| " Primary outcomes were the proportions of patients at 6 months after the intervention who had had any of three clinically important errors: non-selective non-steroidal anti-inflammatory drugs (NSAIDs) prescribed to those with a history of peptic ulcer without co-prescription of a proton-pump inhibitor; β blockers prescribed to those with a history of asthma; long-term prescription of angiotensin converting enzyme (ACE) inhibitor or loop diuretics to those 75 years or older without assessment of urea and electrolytes in the preceding 15 months." | 5.16 | A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. ( Armstrong, S; Avery, AJ; Boyd, M; Cantrill, JA; Cresswell, K; Eden, M; Elliott, RA; Franklin, M; Howard, R; Kendrick, D; Morris, CJ; Prescott, RJ; Putman, K; Rodgers, S; Sheikh, A; Swanwick, G, 2012) |
| " We utilized mass spectrometry to measure EBC purine biomarkers adenosine and AMP plus urea to control for dilutional variability in two studies: 1) a cross-sectional analysis of 28 healthy, 40 cystic fibrosis (CF), and 11 asthmatic children; and 2) a longitudinal analysis of 26 CF children before and after treatment of a pulmonary exacerbation." | 5.14 | Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis. ( Boucher, RC; Boysen, G; Collins, LB; Esther, CR; Ghio, AJ; Olsen, BM; Swenberg, JW, 2009) |
| "We examined whether a combination of glucocorticoids and beta-agonists inhaled by asthmatics had an influence on the metabolism of L-arginine, an amino acid involved in the production of urea, creatinine, and NO that is known to play a significant role in asthma." | 5.10 | Creatininuria in asthmatic children treated with a combination of glucocorticoid and beta-agonist. ( Ferrières, J; Giroux, M, 2003) |
| " We examined the effect of 1 week treatment with BAY 19-8004 (5 mg once daily), a novel orally administered PDE4 inhibitor, on trough FEV1 and markers of inflammation in induced sputum in patients with asthma or chronic obstructive pulmonary disease (COPD)." | 5.10 | Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD). ( Benschop, N; Gauw, SA; Grootendorst, DC; Hiemstra, PS; Rabe, KF; Sterk, PJ, 2003) |
| " Because leukotrienes are putative mediators of bronchial asthma, the effects of a lipoxygenase inhibitor, VZ564 (N-hydroxy-N-(6-methoxy-3,4-dihydro-2- naphthylmethyl) urea." | 3.69 | Effect of the lipoxygenase inhibitor N-hydroxy-N-(6-methoxy-3,4-dihydro-2-naphthylmethyl)urea on bronchoconstriction and lung vascular permeability in anaphylactic guinea pigs. ( Geist, C; Schneider, J; Zimmer, O, 1995) |
| " This study was done to determine the effects of exposure to urea-formaldehyde foam insulation (UFFI) off products on various hematologic and immunologic parameters in subjects with asthma: complete blood count and differential, erythrocyte sedimentation rate, lymphocyte subpopulations (E-rosetting, T3, T4, T8, B73." | 3.67 | Immunologic studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI) off products. ( Clark, RH; Day, JH; Lees, RE; Pross, HF, 1987) |
| "Two carpenters developed asthma and rhinitis related to occupational exposure to a cedar urea formaldehyde (CUF) particle board." | 3.66 | Occupational asthma caused by cedar urea formaldehyde particle board. ( Cockcroft, DW; Dolovich, J; Hoeppner, VH, 1982) |
| "A patient developed severe asthma following insulation of her house with urea-formaldehyde foam." | 3.66 | Asthma induced by dust from urea-formaldehyde foam insulating material. ( Filley, WV; Frigas, E; Reed, CE, 1981) |
| "In asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis, increased arginase activity in the airways may contribute to obstruction and hyperresponsiveness of the airways by inducing a reduction in the production of bronchodilatory nitric oxide (NO) that results from its competition with constitutive (cNOS) and inducible (iNOS) NO synthases for their common substrate." | 2.44 | Arginase and pulmonary diseases. ( Maarsingh, H; Meurs, H; Pera, T, 2008) |
| "Urea is a non-volatile molecule ex vivo and EBC urea depends on its concentrations in plasma." | 1.35 | Urea in exhaled breath condensate of uraemics and patients with chronic airway diseases. ( Acampa, O; Andreoli, R; Bertorelli, G; Corradi, M; David, S; Folesani, G; Franchini, I; Goldoni, M; Manini, P, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 15 (32.61) | 18.7374 |
| 1990's | 10 (21.74) | 18.2507 |
| 2000's | 11 (23.91) | 29.6817 |
| 2010's | 9 (19.57) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, D | 1 |
| Chen, Y | 1 |
| Ding, Y | 1 |
| Tu, J | 1 |
| Ribaldone, DG | 1 |
| Saracco, G | 1 |
| Pellicano, R | 1 |
| Sun, Q | 3 |
| Fang, L | 1 |
| Tang, X | 1 |
| Lu, S | 3 |
| Tamm, M | 1 |
| Stolz, D | 1 |
| Roth, M | 2 |
| Koskela, HO | 1 |
| Salonen, PH | 1 |
| Niskanen, L | 1 |
| Liu, L | 1 |
| Tian, J | 1 |
| He, Q | 1 |
| Zhong, B | 2 |
| Bao, R | 1 |
| Lan, X | 2 |
| Jiang, C | 1 |
| Sun, J | 2 |
| Yang, X | 2 |
| Vandenplas, O | 1 |
| Hereng, MP | 1 |
| Heymans, J | 1 |
| Huaux, F | 1 |
| Lilet-Leclercq, C | 1 |
| Dezfoulian, B | 1 |
| Grand, JL | 1 |
| Thimpont, J | 1 |
| Jin, J | 1 |
| Wang, Y | 1 |
| Shi, D | 1 |
| Wang, F | 1 |
| Fu, W | 1 |
| Davis, RS | 1 |
| Jin, Q | 1 |
| Foley, JJ | 1 |
| Sarau, HM | 2 |
| Morrow, DM | 1 |
| Moore, ML | 1 |
| Rivero, RA | 1 |
| Palovich, M | 1 |
| Salmon, M | 1 |
| Belmonte, KE | 1 |
| Busch-Petersen, J | 1 |
| Folesani, G | 1 |
| Corradi, M | 1 |
| Goldoni, M | 1 |
| Manini, P | 1 |
| Acampa, O | 1 |
| Andreoli, R | 1 |
| Bertorelli, G | 1 |
| David, S | 1 |
| Franchini, I | 1 |
| Esther, CR | 1 |
| Boysen, G | 1 |
| Olsen, BM | 1 |
| Collins, LB | 1 |
| Ghio, AJ | 1 |
| Swenberg, JW | 1 |
| Boucher, RC | 1 |
| Jain, V | 1 |
| Pandey, A | 1 |
| Gupta, S | 1 |
| Mohan, CG | 1 |
| Komai, M | 1 |
| Tanaka, H | 1 |
| Nagao, K | 1 |
| Ishizaki, M | 1 |
| Kajiwara, D | 1 |
| Miura, T | 1 |
| Ohashi, H | 1 |
| Haba, T | 1 |
| Kawakami, K | 1 |
| Sawa, E | 1 |
| Yoshie, O | 1 |
| Inagaki, N | 1 |
| Nagai, H | 1 |
| Ogino, K | 1 |
| Obase, Y | 1 |
| Takahashi, N | 1 |
| Shimizu, H | 1 |
| Takigawa, T | 1 |
| Wang, DH | 1 |
| Ouchi, K | 1 |
| Oka, M | 1 |
| Avery, AJ | 1 |
| Rodgers, S | 1 |
| Cantrill, JA | 1 |
| Armstrong, S | 1 |
| Cresswell, K | 1 |
| Eden, M | 1 |
| Elliott, RA | 1 |
| Howard, R | 1 |
| Kendrick, D | 1 |
| Morris, CJ | 1 |
| Prescott, RJ | 1 |
| Swanwick, G | 1 |
| Franklin, M | 1 |
| Putman, K | 1 |
| Boyd, M | 1 |
| Sheikh, A | 1 |
| Jiao, F | 1 |
| Li, C | 1 |
| Li, D | 1 |
| Giroux, M | 2 |
| Brémont, F | 1 |
| Salles, JP | 1 |
| Rey, E | 1 |
| Della Massa, JP | 1 |
| Ferrières, J | 2 |
| Miralles, JC | 1 |
| Negro, JM | 1 |
| Alonso, JM | 1 |
| García, M | 1 |
| Sánchez-Gascón, F | 1 |
| Soriano, J | 1 |
| BISERTE, G | 1 |
| HAVEZ, R | 1 |
| CUVELIER, R | 1 |
| BRADLEY, RD | 1 |
| SPENCER, GT | 1 |
| SEMPLE, SJ | 1 |
| Grootendorst, DC | 1 |
| Gauw, SA | 1 |
| Benschop, N | 1 |
| Sterk, PJ | 1 |
| Hiemstra, PS | 1 |
| Rabe, KF | 1 |
| Maarsingh, H | 1 |
| Pera, T | 1 |
| Meurs, H | 1 |
| Boggs, PB | 1 |
| Cockcroft, DW | 1 |
| Hoeppner, VH | 1 |
| Dolovich, J | 1 |
| Newhouse, MT | 1 |
| Frigas, E | 1 |
| Filley, WV | 1 |
| Reed, CE | 1 |
| Geist, C | 1 |
| Schneider, J | 1 |
| Zimmer, O | 1 |
| Chabot-Fletcher, MC | 1 |
| Underwood, DC | 1 |
| Breton, JJ | 1 |
| Adams, JL | 1 |
| Kagey-Sobotka, A | 2 |
| Griswold, DE | 1 |
| Marshall, LA | 1 |
| Winkler, JD | 1 |
| Hay, DW | 1 |
| Wood, RA | 1 |
| Shamsuddin, M | 1 |
| Chen, E | 1 |
| Anderson, J | 1 |
| Smith, LJ | 1 |
| Ballal, SG | 1 |
| Ali, BA | 1 |
| Albar, AA | 1 |
| Ahmed, HO | 1 |
| al-Hasan, AY | 1 |
| Lemjabbar, H | 1 |
| Gosset, P | 1 |
| Lamblin, C | 1 |
| Tillie, I | 1 |
| Hartmann, D | 1 |
| Wallaert, B | 1 |
| Tonnel, AB | 1 |
| Lafuma, C | 1 |
| Wilson, DR | 1 |
| Merrett, TG | 1 |
| Varga, EM | 1 |
| Smurthwaite, L | 1 |
| Gould, HJ | 1 |
| Kemp, M | 1 |
| Hooper, J | 1 |
| Till, SJ | 1 |
| Durham, SR | 1 |
| Kirkham, S | 1 |
| Sheehan, JK | 1 |
| Knight, D | 1 |
| Richardson, PS | 1 |
| Thornton, DJ | 1 |
| Ward, C | 1 |
| Duddridge, M | 1 |
| Fenwick, J | 1 |
| Williams, S | 1 |
| Gardiner, PV | 1 |
| Hendrick, DJ | 1 |
| Walters, EH | 1 |
| Out, TA | 2 |
| van de Graaf, EA | 2 |
| Jansen, HM | 2 |
| van den Berg, NJ | 1 |
| Liu, MC | 1 |
| Hubbard, WC | 1 |
| Proud, D | 1 |
| Stealey, BA | 1 |
| Galli, SJ | 1 |
| Bleecker, ER | 1 |
| Lichtenstein, LM | 1 |
| Pross, HF | 1 |
| Day, JH | 1 |
| Clark, RH | 1 |
| Lees, RE | 1 |
| Green, M | 1 |
| Lim, KH | 1 |
| Hutchinson, H | 1 |
| Bedford, S | 1 |
| Kuzemko, JA | 1 |
| Walsh, M | 1 |
| Marriott, C | 1 |
| Richards, JH | 1 |
| Silverman, M | 1 |
| Connolly, NM | 1 |
| Balfour-Lynn, L | 1 |
| Godfrey, S | 1 |
| Cade, JF | 1 |
| Pain, MC | 2 |
| Paskova, Z | 1 |
| Hodek, B | 1 |
| Miklikova, Z | 1 |
| Denborough, MA | 1 |
| Laursen, B | 1 |
| Gormsen, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Generating Recommendations for National Roll-out and Sustainable Use of Prescribing Safety Indicator Based Interventions Using Longitudinal Process Evaluation and a Consolidated Learning Exercise[NCT04766619] | 390 participants (Anticipated) | Observational | 2018-02-16 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for urea and Asthma
| Article | Year |
|---|---|
Arginase and pulmonary diseases.
Topics: Animals; Arginase; Arginine; Asthma; Cystic Fibrosis; Disease Models, Animal; Humans; Hypertension, | 2008 |
7 trials available for urea and Asthma
| Article | Year |
|---|---|
Mass spectrometric analysis of biomarkers and dilution markers in exhaled breath condensate reveals elevated purines in asthma and cystic fibrosis.
Topics: Adenosine; Adenosine Monophosphate; Adolescent; Asthma; Biomarkers; Breath Tests; Child; Child, Pres | 2009 |
A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia A | 2012 |
Creatininuria in asthmatic children treated with a combination of glucocorticoid and beta-agonist.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Albuterol; Anti-Asthmatic Agents; Asthma; Becl | 2003 |
Efficacy of the novel phosphodiesterase-4 inhibitor BAY 19-8004 on lung function and airway inflammation in asthma and chronic obstructive pulmonary disease (COPD).
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Asthma; B | 2003 |
Long-term trial of disodium cromoglycate and isoprenaline in children with asthma.
Topics: Asthma; Blood Cell Count; Bronchial Diseases; Child; Clinical Trials as Topic; Cromolyn Sodium; Eosi | 1972 |
Lung function in provoked asthma: responses to inhaled urea, methacholine and isoprenaline.
Topics: Adolescent; Adult; Aged; Airway Resistance; Asthma; Carbon Dioxide; Female; Humans; Hypoxia; Isoprot | 1972 |
The acute action of urea on ventilatory function in patients with asthma.
Topics: Adult; Aerosols; Aged; Asthma; Clinical Trials as Topic; Female; Humans; Isoproterenol; Male; Middle | 1967 |
38 other studies available for urea and Asthma
| Article | Year |
|---|---|
Inverse association between Helicobacter pylori infection and childhood asthma in a physical examination population: a cross-sectional study in Chongqing, China.
Topics: Asthma; Body Mass Index; Breath Tests; Child; Child, Preschool; China; Cross-Sectional Studies; Fema | 2022 |
Does Helicobacter pylori infection increase the risk of adult-onset asthma?
Topics: Adult; Asthma; Breath Tests; Helicobacter Infections; Helicobacter pylori; Humans; Risk; Sensitivity | 2017 |
TGF-β Upregulated Mitochondria Mass through the SMAD2/3→C/EBPβ→PRMT1 Signal Pathway in Primary Human Lung Fibroblasts.
Topics: Airway Remodeling; Asthma; Cells, Cultured; Chaperonin 60; Fibroblasts; Humans; Imidazoles; Mitochon | 2019 |
Hyperglycaemia during exacerbations of asthma and chronic obstructive pulmonary disease.
Topics: Acute Disease; Aged; Aged, 80 and over; Asthma; Blood Glucose; C-Reactive Protein; Comorbidity; Diab | 2013 |
PRMT1 Upregulated by Epithelial Proinflammatory Cytokines Participates in COX2 Expression in Fibroblasts and Chronic Antigen-Induced Pulmonary Inflammation.
Topics: Acute Disease; Animals; Antibodies; Asthma; Cell Proliferation; Chronic Disease; Culture Media, Cond | 2015 |
Respiratory and skin hypersensitivity reactions caused by a peptide coupling reagent.
Topics: Adult; Asthma; Dermatitis, Contact; Dermatitis, Occupational; Female; Humans; Male; Middle Aged; Res | 2008 |
Muscarinic acetylcholine receptor antagonists: SAR and optimization of tyrosine ureas.
Topics: Asthma; Chemistry, Pharmaceutical; Drug Design; Humans; Inhibitory Concentration 50; Models, Chemica | 2008 |
Urea in exhaled breath condensate of uraemics and patients with chronic airway diseases.
Topics: Adult; Asthma; Breath Tests; Cystic Fibrosis; Female; Humans; Male; Middle Aged; Pulmonary Disease, | 2008 |
Ligand-based molecular design of 4-benzylpiperidinealkylureas and amides as CCR3 antagonists.
Topics: Amides; Asthma; Benzene Derivatives; Drug Design; Humans; Ligands; Quantitative Structure-Activity R | 2010 |
A novel CC-chemokine receptor 3 antagonist, Ki19003, inhibits airway eosinophilia and subepithelial/peribronchial fibrosis induced by repeated antigen challenge in mice.
Topics: Airway Remodeling; Animals; Asthma; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dose-Respo | 2010 |
High serum arginase I levels in asthma: its correlation with high-sensitivity C-reactive protein.
Topics: Adult; Aged; Alanine Transaminase; Arginase; Asthma; C-Reactive Protein; Enzyme-Linked Immunosorbent | 2011 |
Upregulated protein arginine methyltransferase 1 by IL-4 increases eotaxin-1 expression in airway epithelial cells and participates in antigen-induced pulmonary inflammation in rats.
Topics: Animals; Antigens; Asthma; Chemokine CCL11; Disease Models, Animal; Drug Evaluation, Preclinical; Ep | 2012 |
Exhaled NH3 and excreted Nh4+ in children in unpolluted or urban environments.
Topics: Air Pollutants; Ammonia; Asthma; Breath Tests; Case-Control Studies; Child; Environmental Monitoring | 2002 |
Occupational rhinitis and bronchial asthma due to TBTU and HBTU sensitization.
Topics: Adult; Asthma; Drug Industry; Humans; Immunization; Male; Occupational Diseases; Occupational Exposu | 2003 |
[THE GLYCOPROTEINS OF BRONCHIAL SECRETIONS].
Topics: Antibodies; Asthma; Beta-Globulins; Blood Group Antigens; Bronchitis; Chromatography; Chymotrypsin; | 1963 |
TRACHEOSTOMY AND ARTIFICIAL VENTILATION IN THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC LUNG DISEASE. A STUDY IN TWENTY-NINE PATIENTS.
Topics: Asthma; Blood Chemical Analysis; Blood Gas Analysis; Bronchitis; Bronchopneumonia; Geriatrics; Human | 1964 |
Occupational asthma and rhinitis caused by urea formaldehyde?
Topics: Asthma; Construction Materials; Formaldehyde; Humans; Occupational Diseases; Rhinitis; Urea | 1983 |
Occupational asthma caused by cedar urea formaldehyde particle board.
Topics: Asthma; Formaldehyde; Humans; Male; Middle Aged; Occupational Diseases; Rhinitis, Allergic, Perennia | 1982 |
UFFI dust: nonspecific irritant only?
Topics: Asthma; Construction Materials; Female; Formaldehyde; Humans; Research Design; Urea | 1982 |
Asthma induced by dust from urea-formaldehyde foam insulating material.
Topics: Asthma; Bronchial Provocation Tests; Construction Materials; Dust; Female; Formaldehyde; Humans; Mid | 1981 |
Effect of the lipoxygenase inhibitor N-hydroxy-N-(6-methoxy-3,4-dihydro-2-naphthylmethyl)urea on bronchoconstriction and lung vascular permeability in anaphylactic guinea pigs.
Topics: Anaphylaxis; Animals; Asthma; Bronchoconstriction; Capillary Permeability; Guinea Pigs; In Vitro Tec | 1995 |
Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.
Topics: Animals; Antigens; Asthma; Benzofurans; Bronchoconstriction; Disease Models, Animal; Eosinophils; Gu | 1995 |
Indoor allergens: thrill of victory or agony of defeat?
Topics: Air Pollution, Indoor; Allantoin; Allergens; Animals; Asthma; Benzoates; Cats; Collagen; Dermatitis, | 1997 |
Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages.
Topics: Acetyltransferases; Acyl-Carrier Protein S-Acetyltransferase; Arachidonic Acids; Asthma; Benzenesulf | 1997 |
Bronchial asthma in two chemical fertilizer producing factories in eastern Saudi Arabia.
Topics: Adult; Ammonia; Asthma; Bronchitis; Chronic Disease; Cross-Sectional Studies; Fertilizers; Humans; L | 1998 |
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus.
Topics: Adult; Albumins; Asthma; Body Water; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoscopy; Collagenas | 1999 |
Increases in allergen-specific IgE in BAL after segmental allergen challenge in atopic asthmatics.
Topics: Adult; Albumins; Allergens; Asthma; Bronchial Provocation Tests; Bronchoalveolar Lavage Fluid; Femal | 2002 |
Heterogeneity of airways mucus: variations in the amounts and glycoforms of the major oligomeric mucins MUC5AC and MUC5B.
Topics: Asthma; Blotting, Western; Cystic Fibrosis; Dose-Response Relationship, Drug; Electrophoresis, Agar | 2002 |
The origin of water and urea sampled at bronchoalveolar lavage in asthmatic and control subjects.
Topics: Adult; Aged; Asthma; Body Water; Bronchoalveolar Lavage Fluid; Carbon Radioisotopes; Cell Membrane P | 1992 |
Permeability or local production of immunoglobulins and other inflammatory proteins in asthma.
Topics: Adolescent; Adult; Aged; Asthma; Bronchoalveolar Lavage Fluid; Complement C3; Female; Humans; Immuno | 1991 |
IgG subclasses in bronchoalveolar lavage fluid from patients with asthma.
Topics: Adolescent; Adult; Aged; Albumins; Asthma; Bronchoalveolar Lavage Fluid; Ceruloplasmin; Enzyme-Linke | 1991 |
Immediate and late inflammatory responses to ragweed antigen challenge of the peripheral airways in allergic asthmatics. Cellular, mediator, and permeability changes.
Topics: Adult; Albumins; Antigens; Asthma; Bronchi; Bronchoalveolar Lavage Fluid; Bronchoconstriction; Cell | 1991 |
Immunologic studies of subjects with asthma exposed to formaldehyde and urea-formaldehyde foam insulation (UFFI) off products.
Topics: Antibody Formation; Antigens, Tumor-Associated, Carbohydrate; Asthma; Cytotoxicity, Immunologic; Dis | 1987 |
Bronchial asthma with Addison's disease.
Topics: Addison Disease; Adrenal Cortex Hormones; Adult; Asthma; Humans; Hypotension; Male; Sodium; Urea | 1971 |
Renal tubular function in asthmatic children on long-term disodium cromoglycate.
Topics: Adolescent; Asthma; Bicarbonates; Child; Chlorides; Creatinine; Cromolyn Sodium; Female; Humans; Iso | 1972 |
The effects of storage and of potassium iodide, urea, N-acetyl-cysteine and triton X-100 on the viscosity of bronchial mucus.
Topics: Acetylcysteine; Asthma; Bronchi; Bronchitis; Centrifugation; Humans; Mucus; Polyethylene Glycols; Po | 1974 |
[Experience with Lysenyl in allergology].
Topics: Adolescent; Adult; Aged; Asthma; Child; Chronic Disease; Conjunctivitis; Eczema; Ergolines; Female; | 1972 |
Pharmacological enhancement and short-term stimulation of blood fibrinolytic activity.
Topics: Adolescent; Adult; Aged; Aminocaproates; Anticholesteremic Agents; Arteriosclerosis; Arthritis, Rheu | 1969 |